Synapse - Mark Kris

Results (873)

A pilot study comparing computerized volume measurement with diameter measurement as an early biomarker of the biologic activity of EGFR targeted therapy

Meeting Abstract

Zhao, B. S.; Oxnard, G. R.; Guo, P. Z.; Rizvi, N. A.; Kris, M. G.; Schwartz, L. H.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Reflex testing of lung adenocarcinomas for EGFR and KRAS mutations: The initial Memorial Sloan-Kettering Cancer Center (MSKCC) experience

Meeting Abstract

Zakowski, M. F.; Ladanyi, M.; Rekhtman, N.; Park, B.; Finley, D.; Azzoli, C.; Kris, M. G.; Rusch, V.; Miller, V.; Riely, G.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Comparison of CISH and FISH for detection of EGFR copy number in lung adenocarcinomas and correlation with EGFR and KRAS mutation status and EGFR immunohistochemistry reactivity

Meeting Abstract

Varella, G. M.; Ladanyi, M.; Kris, M. G.; Rekhtman, N.; Hirsch, F.; Miller, V.; Riely, G.; Pao, W.; Zakowski, M. F.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Phase 1 trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib

Meeting Abstract

Riely, G. J.; Janjigian, Y. Y.; Pereira, L. K.; Azzoli, C. G.; Pietanza, M. C.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; more...
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer

Meeting Abstract

Pietanza, M. C.; Pereira, L.; Dunne, M.; Travis, W. D.; Chan, T. A.; Ginsberg, M. S.; Holodny, A.; Kris, M. G.; Krug, L. M.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Rebiopsy of patients with "acquired resistance" to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC)

Meeting Abstract

Miller, V. A.; Riely, G. J.; Arcila, M. E.; Oxnard, G.; Zakowski, M. F.; Kris, M. G.; Pao, W.; Ladanyi, M.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Using biomarkers to predict response to EGFR inhibitors

Meeting Abstract

Kris, M. G.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Phase II trial of induction and adjuvant bevacizumab with cisplatin and docetaxel in patients with locally advanced NSCLC

Meeting Abstract

Kris, M. G.; Price, K. A.; Rusch, V. W.; Zhao, B. S.; Schwartz, L. H.; Guo, P. Z.; Tan, Y. Q.; Subzwari, S.; Finley, D.; Rizvi, N. A.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Phase II trial of dasatinib for patients demonstrating acquired resistance to treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) erlotinib (E) or gefitinib (G)

Meeting Abstract

Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; Miller, V. A.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Prognostic implications of EGFR and KRAS gene mutations in resected lung adenocarcinoma

Meeting Abstract

Janjigian, Y. Y.; Kris, M. G.; Pao, W.; Marks, J.; Zheng, J.; Shen, R.; Dycoco, J.; Park, B. J.; Riely, G. J.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save